Events & Webinars

Upcoming Events

Conference

AAIC 2024 Annual Conference

Jul 28- Aug 1  | Philadelphia, PA

Booth #936

product theater

July 30, 12:25 -1:05 PM ET

pTau and Beyond- High sensitivity, multiplexed analysis of CNS disease biomarkers from biofluids.

Amanda Heslegrave, PhD
University College London

Thomas K. Karikari, PhD
University of Pittsburgh

poster #89847

July 31, 8:00 AM – 4:15 PM ET

Development of NULISA™ CNS Disease Panel 120 for comprehensive proteomics profiling of neuro degenerative diseases

Xiao-Jun Ma, PhD
Alamar Biosciences

On-Demand Webinars

virtual_event_header_banner_image_ffbbaf61a3b481ae34b1b40096534c7cf70c7e73_1015 (1)

A Blood Test for Alzheimer’s Disease – Thinking Beyond a Diagnosis

SPEAKERS

Alex Forrest-Hay
Alamar Biosciences

Xiao-Jun Ma
Alamar Biosciences

Yuehan Feng
Biognosys

virtual_event_profile_image_99a0dd4eb5a626def38ae9f13e0f652fc610ec8f_5771

A Blood Test for Alzheimer’s Disease – Thinking Beyond a Diagnosis

SPEAKERS

Nicholas Ashton, PhD
University of Gothenburg

Alex Forrest-Hay
Alamar Biosciences

NULISA: Ultra-sensitive immunoassay platform for profiling fluid-based neurodegenerative protein biomarkers

SPEAKERS

Henrik Zetterberg, MD, PhD
University of Gothenburg

Doug Hinerfeld, PhD
Alamar Biosciences

Comprehensive profiling of 200+ proteins using the NULISAseq Inflammation Panel reveals unique signatures of immune response in AML

SPEAKERS

Hussein Abbas, PhD
MD Anderson

Alex Forrest-Hay
Alamar Biosciences

Comparison of multiplexed platforms for serum cytokine detection in COVID-19 patients

SPEAKERS

Holden Maecker, PhD
Stanford University

Alex Forrest-Hay
Alamar Biosciences

Inflammatory Protein Signatures Associated with Proneness to Early Life Infection and Asthma

SPEAKERS

Jessica Laskey-Su, DSc, MS
Harvard Medical School and Brigham and Women’s Hospital

Alex Forrest-Hay
Alamar Biosciences

NULISA: A precision proteomics platform with ultra-high sensitivity and high multiplex for liquid biopsy samples.

SPEAKERS

Alex Forrest-Hay
Alamar Biosciences

Past Events

seminar

Alamar Precision Biomarker Summit - Berlin

July 3 | Berlin, Germany

Advances in high sensitivity, comprehensive profiling of immune response with the NULISA™ platform.

SPEAKERS INCLUDE:

Eicke Latz, MD, PHD
DRFZ 

Susanne Schmidt, PhD
University of Bonn

Amy Anderson, PhD
Newcastle University

Chotima Boettcher, PhD
Charite, Berlin

Mike Evans
Alamar Biosciences

Conference

FOCIS: Federation of Clinical Immunology Societies Annual Meeting

June 18-21  | San Francisco, CA

INDUSTRY LUNCH TUTORIAL

June 20, 11:45 AM – 1:00 PM PT

Comprehensive protein profiling of inflammation at attomolar sensitivity provides novel insights into mechanisms of immune response.

Christopher Bunker, PhD
Alamar Biosciences

Holden Maecker, PhD
Stanford University

conference

Festival of Genomics & Biodata

June 12-13 | Boston, MA

Industry Partner

Sponsor Talk

June 12, 4:20 PM ET

Introducing NULISA – Precision Proteomics for Early Disease Detection

Alex Forrest-Hay
Alamar Biosciences

conference

Keystone Symposia: Neurodegenerative Diseases

June 3-6 | Santa Fe, NM

POSTER

Track: Z4: Neuroimmune Interactions: Nervous System and Immune Cell Heterogeneity in Health and Disease

Tau and Beyond: Proteomic profiling of neurodegenerative diseases with a 120-plex CNS disease panel 

Douglas Hinerfeld, PhD
Alamar Biosciences

conference

Hanson Wade: Alzheimer's and Parkinson's Drug Development Summit

April 23-25  | Boston, MA

Expertise Partner

PRESENTATION

April 25, 9:00 AM ET

NULISA: Ultra-sensitive and multiplex immunoassay platform for fluid-based neurodegenerative biomarker detection.

Christopher Bunker, PhD
Alamar Bioscience

conference

ABRF Annual Meeting

April 21-24 | Minneapolis, MN

Gold & Silver Sponsor

Technology Showcase

April 23, 4:30 PM CT

Complementing Mass Spec analysis with ultra-sensitive fluid biomarker detection using the NULISA platform.

Peter Vuong
Alamar Bioscience

Technology Showcase

April 24, 8:00-9:00 AM CT

High sensitivity proteomics at the push of a button.

Peter Vuong
Alamar Bioscience

Adam Richardson
Panome Bio

Booth #102/104

conference

AACR 2024

April 5-10  | San Diego, CA

SPOTLIGHT THEATER

April 9, 12:30-1:30 PM PT

Advances in high sensitivity protein detection from biofluids and the potential in early diagnosis and therapeutic monitoring.

Yuehan Feng, PhD
Biognosys

Yuling Luo, PhD
Alamar Bioscience

Booth #4315/4317

conference

Hanson Wade: Neuroimmunology and Drug Development Summit

March 25-27  | Boston, MA

Expertise Partner

PRESENTATION

March 26, 9:30 AM ET

NULISA: Ultra-sensitive and multiplex immunoassay platform for fluid biomarkers in CNS Disease.

Christopher Bunker, PhD
Alamar Bioscience

CONFERENCE

World Immune Regulation 2024

March 13-16 | Davos, Switzerland

Poster

March 15, 8:00 PM – Session P7

Immune Profiling of Autoimmune Diseases with NULISAseq 250-Plex Inflammation Panel

Xiao-Jun Ma, PhD
Alamar Biosciences

CONFERENCE

US HUPO 2024

March 9-13 | Portland, OR

Gold Sponsor

Breakfast Seminar

March 12, 7:15AM – 8:15AM

Poster & Lightning talk

March 12, 11:00AM – 12:15PM
& 1:30PM – 3:00PM

Mining the plasma proteome; a novel ultrasensitive and high-plex liquid biopsy platform reveals changes in biologically important low-abundance biomarkers

Yuling Luo, PhD
Alamar Biosciences

Annual Meeting

March 5-9 | Lisbon, Portugal

General Sponsor

Product Theatre

March 6, 1:00PM

Biofluid-based biomarkers for Alzheimer’s Disease and related disorders – precision, panels and patterns 

Henrik Zetterberg, MD, PhD
University of Gothenburg

Douglas Hinerfield, PhD
Alamar Biosciences

Poster

March 8-9, 9:00AM – 6:00PM

Development of NULISA™ CNS Disease Panel for Comprehensive Proteomic Profling of Neurodegenerative Diseases

Xiao-Jun Ma, PhD
Alamar Biosciences

Booth: #04A

Biomarkers 2024

February 29-March 1 | London, England

Program Sponsor

PRESENTATION

March 1, 1:10PM

Introducing NULISA – A New Ultra-Sensitive
Proteomics Platform For Profiling Low
Abundant Fluid-Based Inflammatory And
Neurodegenerative Disease Biomarkers In
Highly Multiplex Panels

Barry Lynch
Alamar Biosciences

CONFERENCE

General Meeting 2024

February 5-8 | Orlando, FL

Poster

Mining the plasma proteome; a novel ultrasensitive and high-plex liquid biopsy platform reveals changes in biologically important low-abundance biomarkers

Yuling Luo, PhD
Alamar Biosciences

CONFERENCE

Precision Medicine World Conference 2024

Annual Meeting 2024

January 24-26  | San Jose, CA

Bronze Sponsor

PRESENTATION

January 26, 2:00 PM – Track 4

NULISA: Fully automated
ultra-sensitive proteomics platform for profiling biofluid samples 

Alex Forrest-Hay
Alamar Biosciences

Booth: #D1248

CONFERENCE

NERLSCD 2023

October 18-20  | Burlington, VT

Gold Sponsor

CONFERENCE

2023 Midwest Association of Core Directors (MWACD) Annual Meeting

October 16-17  | Ann Arbor, MI

Titanium Sponsor

WACD 2023

October 12-13, 2023 | Portland, OR

Gold Sponsor

Hanson Wade Fluid & Imaging Biomarkers in Neuroscience

August 22-24, 2023 | Boston, MA

NULISA: Ultra-sensitive immunoassay platform for fluid-based neurodegenerative biomarker detection

Speakers:

Christopher Bunker, PhD
Alamar Biosciences

CONFERENCE

July 16-20  | Amsterdam, The Netherlands

Booth# 706

Product Theater:

Ultra-sensitive immunoassay platform for profiling fluid-based neurodegenerative protein biomarkers

Speakers:

Henrik Zetterberg, MD, PhD
University of Gothenburg

Doug Hinerfeld, PhD
Alamar Bio

Poster :
A novel automated multiplex immunoassay for the ultrasensitive detection of blood-based biomarkers for neurodegenerative diseases

CONFERENCE

June 20-23, 2023 | Boston, MA

Booth# 8

Industry Tutorial:

Advances in blood-based profiling of immune response biomarkers

Speakers:

Holden T. Maecker, PhD
Stanford University

Christopher Bunker, PhD
Alamar Bio

Poster :
Ultra-sensitive Immune Profiling of Autoimmune Diseases with 200-Plex NULISAseq™ Inflammation Panel

CONFERENCE

June 20-21, 2023 | Philadelphia, PA

Panel: 

Multiomics in Neurodegenerative Diseases

Speakers:

Yuling Luo, PhD
Alamar Bio

Hanson Wade Neuroimmunology Drug Development Summit

April 25-27, 2023 | Boston, MA

NULISA: Ultra-sensitive immunoassay platform for fluid-based neurodegenerative biomarker detection

Speakers:

Christopher Bunker, PhD
Alamar Biosciences

Immunology 2023 (AAI)

May 11-15, 2023 | Washington, D.C.

Booth# 7144

Workshop

Speakers:

Susanne Schmidt, PhD
University Hospital Bonn